Callum Jeannie L, Merkley Lisa L, Coovadia Ahmed S, Lima Ana P, Kaplan Harold S
Department of Clinical Pathology, Sunnybrook and Women's College Health Sciences Centre, and The University of Toronto, 2075 Bayview Avenue, Toronto, Ont., Canada.
Transfus Apher Sci. 2004 Oct;31(2):133-43. doi: 10.1016/j.transci.2004.07.007.
The MERS-TM assists hospital transfusion services to identify, analyze, and correct system events relating to the delivery of blood to patients.
The MERS-TM system was used from February of 1999 to December 2002. All reported near-miss and actual events were recorded and analyzed.
During these 47 months, 4670 events were reported by the transfusion service. Of these events, 94% were classified as a near-miss event and 93% were detected before the blood product was administered. No ABO-incompatible transfusions were detected despite transfusion of 50,137 units of red blood cells. High severity events with the potential for patient harm accounted for 241 (5%) of the 4670 events. Nursing related events accounted for 188 (78%) of the high severity events. In one out of 4430 (0.023%) samples tested, a high severity sample-testing event was detected. In one out of 1550 (0.06%) samples collected, a high severity sample-collection event was detected.
An event reporting system is essential if one is to determine where and how often events are occurring within the transfusion process.
中东呼吸综合征输血监测(MERS-TM)有助于医院输血服务部门识别、分析和纠正与向患者输血相关的系统事件。
1999年2月至2002年12月使用MERS-TM系统。记录并分析所有报告的险些发生的事件和实际事件。
在这47个月期间,输血服务部门报告了4670起事件。在这些事件中,94%被归类为险些发生的事件,93%在血液制品输注前被发现。尽管输注了50137单位红细胞,但未检测到ABO血型不相容的输血情况。4670起事件中有241起(5%)是可能对患者造成伤害的高严重度事件。护理相关事件占高严重度事件的188起(78%)。在4430个(0.023%)检测样本中,有1个检测到高严重度样本检测事件。在1550个(0.06%)采集样本中,有1个检测到高严重度样本采集事件。
如果要确定输血过程中事件发生的地点和频率,事件报告系统至关重要。